CLOZOLE-V6 Tablet by Dr Precision is a potent intravaginal antifungal medication formulated with 100 mg of Clotrimazole, specifically designed to treat vulvovaginal candidiasis and other fungal infections of the vaginal mucosa. This vaginal tablet delivers a high concentration of the active antifungal agent directly at the infection site, ensuring targeted, localized therapy that minimizes systemic exposure. Manufactured by BluepillExpress under stringent WHO-GMP quality standards and Dr Precision’s GMP-compliant formulation, CLOZOLE-V6 ensures reliable efficacy and safety during the standard 6-day treatment course. The tablet dissolves at body temperature, facilitating sustained antifungal action right where fungal pathogens like Candida albicans proliferate. Its mechanism involves inhibition of ergosterol synthesis, critical for fungal cell membrane integrity, resulting in fungal cell death and rapid symptom relief. CLOZOLE-V6 is effective not only against primary vulvovaginal candidiasis but also in recurrent cases and mixed infections with a fungal component. Key benefits include minimal disruption to vaginal pH, convenient once-daily dosing with high patient compliance, and proven efficacy in resolving symptoms such as itching, burning, redness, and abnormal discharge, making it an ideal choice for healthcare providers treating female patients with fungal vaginal infections within a professional clinical setting.
Key Features
| Features | Description |
|---|---|
| Active Ingredient | Clotrimazole 100 mg per tablet |
| Indication | Treatment of vulvovaginal candidiasis including recurrent and mixed infections |
| Dosage Form | Intravaginal dissolving tablet |
| Treatment Duration | 6 consecutive days (once daily) |
| Mechanism of Action | Inhibits ergosterol synthesis disrupting fungal cell membranes |
| Manufacturing Standards | WHO-GMP certified by BluepillExpress under Dr Precision label |
| Application Site | Local intravaginal application targeting vaginal mucosa |
| Advantages | Localized delivery minimizing systemic absorption and adverse effects |
| Symptom Relief | Effective against itching, burning, redness, and discharge |
| Compatibility | Maintains natural vaginal pH during treatment |
| Attributes | Description |
|---|---|
| Tablet Weight | Approximate standard vaginal tablet size (exact weight varies) |
| Excipients | Includes lactose, microcrystalline cellulose, starch, and pharmaceutical grade bases |
| Storage Conditions | Store in a cool, dry place away from direct sunlight |
| Packaging | Blister packs suitable for B2B supply chains |
| Shelf Life | Typically 2 years from manufacture date |
| Route of Administration | Intravaginal |
| Treatment Course | 6 days with once daily administration |
| Manufacturer | BluepillExpress under Dr Precision brand |
| Regulatory Compliance | Manufactured according to WHO-GMP standards |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
CLOZOLE-V6 utilizes a specialized dissolving vaginal tablet base which adheres to vaginal mucosa and dissolves at body temperature, ensuring sustained and localized delivery of 100 mg Clotrimazole directly at the infection site for enhanced efficacy.
Due to its intravaginal formulation and local application, CLOZOLE-V6 delivers high concentrations of Clotrimazole at the infection site, substantially reducing systemic absorption and thereby minimizing systemic side effects.
Yes, CLOZOLE-V6 can be used as adjunctive therapy in mixed vaginal infections, but only when a fungal component such as Candida species is confirmed to be part of the infection.
The standard regimen involves inserting one intravaginal tablet once daily at bedtime for six consecutive days to ensure complete eradication of the fungal infection.
The formulation is designed to not interfere with the natural pH of the vaginal environment, thereby preserving the mucosal flora balance while effectively eliminating fungal pathogens.
CLOZOLE-V6 is manufactured under WHO-GMP certified processes by BluepillExpress and follows Dr Precision’s GMP-compliant formulation standards, ensuring pharmaceutical-grade quality and safety.
Country Of Origin: India
CLOZOLE-V6 Tablet is a powerful intravaginal antifungal treatment containing Clotrimazole 100 mg, used to treat vulvovaginal candidiasis and other fungal infections affecting the vaginal mucosa. Each tablet is designed for local application inside the vagina, delivering high concentrations of the active antifungal agent directly to the site of infection. Manufactured by BluepillExpress under WHO-GMP standards, CLOZOLE-V6 provides a safe, effective, and well-tolerated option for restoring vaginal health over a standard 6-day treatment course.
This product is manufactured under the Dr Precision label, ensuring GMP-compliant quality and precision formulation standards.
CLOZOLE-V6 Tablet is a vaginal antifungal formulation used to treat infections caused by Candida species, primarily Candida albicans, which is the most common pathogen responsible for vulvovaginal candidiasis (VVC). The formulation contains Clotrimazole, an imidazole-class antifungal agent, known for its broad-spectrum fungistatic and fungicidal activity. This product is intended for intravaginal use only and is formulated as a vaginal tablet that dissolves at body temperature for localized, sustained antifungal action.
Mechanism of Action:
Clotrimazole exerts its antifungal activity by inhibiting the synthesis of ergosterol, a vital component of fungal cell membranes. This disruption in membrane integrity causes leakage of cellular contents, leading to fungal cell death. The localized vaginal application allows for high drug concentrations directly at the site of infection, resulting in rapid symptom relief and microbial eradication.
Clinical Indications:
CLOZOLE-V6 is primarily indicated for:
Vulvovaginal candidiasis (VVC)
Recurrent yeast infections
Symptomatic relief of itching, burning, and discharge associated with fungal vaginitis
Adjunctive therapy in mixed vaginal infections (when fungal component is confirmed)
Advantages of CLOZOLE-V6:
Delivers targeted therapy to the infection site
Minimizes systemic absorption and adverse effects
Convenient once-daily application over six days
Does not interfere with the natural pH of the vaginal environment
Rapid resolution of clinical symptoms like itching, redness, and discharge
Proven efficacy in single-pathogen and mixed-pathogen infections
Formulation and Composition:
Each vaginal tablet contains:
Clotrimazole IP 100 mg
Excipients: Lactose, microcrystalline cellulose, starch, and other pharmaceutical-grade tablet bases designed to facilitate rapid disintegration and mucosal adherence within the vaginal cavity.
Dosage and Administration:
One vaginal tablet should be inserted deep into the vagina once daily, preferably at bedtime.
The usual course is for 6 consecutive days (hence V6).
Patients should be advised to complete the full course of treatment even if symptoms resolve earlier.
Inclusive of all taxes
You Save: 0
Surat , India
Manufacturer, Contractor, Retailer, Brand Owner, Distributor, Exporter, Importer, Wholesaler, Startup
GST- 24abdfb4194j1ze
